The qCXL platform employs a customised treatment planning engine and real-time ultrasound monitoring for precision.
TECLens treated the first patient in a first-in-human trial assessing safety and efficacy of qCXL-based refractive correction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results